SCHEMBL3517752

SCHEMBL3517752

O=c1c(-c2ccccc2)c(O)c2cc(S(=O)(=O)Nc3ccccc3)cnc2n1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UQCRB P14927 1/20 0.39
PLG P00747 1/20 0.38
PLAU P00749 1/20 0.38
PLAT P00750 1/20 0.38
IL1RN P18510 1/20 0.38
KEAP1 Q14145 1/20 0.38
ERAP1 Q9NZ08 1/20 0.38
PIK3C3 Q8NEB9 1/20 0.37
MAPK8 P45983 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PDE3A Q14432 2/20 0.36
PKM P14618 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
CYTH2 Q99418 1/20 0.36
MET P08581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3515734 0.84 POLB (0.46) KEAP1PIK3C3KDM4EPKMKMT2A
SCHEMBL3518153 0.82 AR (0.39) UQCRBMAPK8PKMKMT2AMEN1
SCHEMBL3525616 0.79 KMT2A (0.43) KDM4EKMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL3515715 0.77 KMT2A (0.42) KDM4EKMT2AMEN1SMN1; SMN2MAPT
SCHEMBL3517548 0.77 KMT2A (0.44) KDM4EPKMKMT2ASMN1; SMN2MAPT
SCHEMBL13435228 0.77 KDM4E (0.47) MAPK8KDM4EKMT2ASMN1; SMN2MAPT
SCHEMBL3516992 0.76 COMT (0.43) KDM4EKMT2ASMN1; SMN2MAPTMET
SCHEMBL3517390 0.74 KDM4E (0.41) KDM4EKMT2ASMN1; SMN2MAPTHTT
SCHEMBL3519938 0.74 IP6K1 (0.41) KDM4EKMT2AMEN1SMN1; SMN2MAPT
SCHEMBL3519936 0.74 IP6K1 (0.41) KDM4EKMT2AMEN1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL UQCRB 1064/4885PLG 2390/4885PLAU 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.